Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3011% above fair value
$262.21+2.61 (+1.01%)
Close on Nov 16, 2026Market cap $28.85BP/E 26.1Yield –
Quest Diagnostics total assets
Total assets on the balance sheet at the end of each period.
Quest Diagnostics's total assets was $17.22B at Sep 30, 2026. For fiscal 2025 it was $16.23B, up 0.4% from the year before. Over ten years it grew 5.0% a year on average. The highest annual figure on record is $16.23B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.23B | +0.4% |
| FY2024 | Dec 31, 2024 | $16.15B | +15.2% |
| FY2023 | Dec 31, 2023 | $14.02B | +9.2% |
| FY2022 | Dec 31, 2022 | $12.84B | -5.7% |
| FY2021 | Dec 31, 2021 | $13.61B | -3.0% |
| FY2020 | Dec 31, 2020 | $14.03B | +9.2% |
| FY2019 | Dec 31, 2019 | $12.84B | +16.7% |
| FY2018 | Dec 31, 2018 | $11.00B | +4.8% |
| FY2017 | Dec 31, 2017 | $10.50B | +4.0% |
| FY2016 | Dec 31, 2016 | $10.10B | +1.4% |
| FY2015 | Dec 31, 2015 | $9.96B | +1.1% |
| FY2014 | Dec 31, 2014 | $9.86B | +10.2% |
| FY2013 | Dec 31, 2013 | $8.95B | -3.6% |
| FY2012 | Dec 31, 2012 | $9.28B | -0.3% |
| FY2011 | Dec 31, 2011 | $9.31B | +9.2% |
| FY2010 | Dec 31, 2010 | $8.53B | -0.4% |
| FY2009 | Dec 31, 2009 | $8.56B | +1.9% |
| FY2008 | Dec 31, 2008 | $8.40B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $17.22B | +6.3% |
| Q2 FY2026 | Jun 30, 2026 | $16.94B | +6.1% |
| Q1 FY2026 | Mar 31, 2026 | $16.67B | +5.5% |
| Q4 FY2025 | Dec 31, 2025 | $16.23B | +0.4% |
| Q3 FY2025 | Sep 30, 2025 | $16.20B | +0.6% |
| Q2 FY2025 | Jun 30, 2025 | $15.97B | +15.0% |
| Q1 FY2025 | Mar 31, 2025 | $15.80B | +13.2% |
| Q4 FY2024 | Dec 31, 2024 | $16.15B | +15.2% |
| Q3 FY2024 | Sep 30, 2024 | $16.10B | +19.4% |
| Q2 FY2024 | Jun 30, 2024 | $13.88B | +3.4% |
| Q1 FY2024 | Mar 31, 2024 | $13.95B | +9.1% |
| Q4 FY2023 | Dec 31, 2023 | $14.02B | +9.2% |
| Q3 FY2023 | Sep 30, 2023 | $13.48B | +2.0% |
| Q2 FY2023 | Jun 30, 2023 | $13.43B | +0.8% |
| Q1 FY2023 | Mar 31, 2023 | $12.79B | -4.8% |
| Q4 FY2022 | Dec 31, 2022 | $12.84B | -5.7% |
| Q3 FY2022 | Sep 30, 2022 | $13.22B | -2.6% |
| Q2 FY2022 | Jun 30, 2022 | $13.31B | +3.5% |
| Q1 FY2022 | Mar 31, 2022 | $13.44B | -3.5% |
| Q4 FY2021 | Dec 31, 2021 | $13.61B | -3.0% |
| Q3 FY2021 | Sep 30, 2021 | $13.57B | -4.0% |
| Q2 FY2021 | Jun 30, 2021 | $12.86B | -1.0% |
| Q1 FY2021 | Mar 31, 2021 | $13.93B | +15.6% |
| Q4 FY2020 | Dec 31, 2020 | $14.03B | +9.2% |
| Q3 FY2020 | Sep 30, 2020 | $14.14B | +17.7% |
| Q2 FY2020 | Jun 30, 2020 | $12.99B | +10.5% |
| Q1 FY2020 | Mar 31, 2020 | $12.05B | +0.9% |
| Q4 FY2019 | Dec 31, 2019 | $12.84B | +16.7% |
| Q3 FY2019 | Sep 30, 2019 | $12.02B | +9.4% |
| Q2 FY2019 | Jun 30, 2019 | $11.76B | +9.4% |
| Q1 FY2019 | Mar 31, 2019 | $11.94B | +11.6% |
| Q4 FY2018 | Dec 31, 2018 | $11.00B | +4.8% |
| Q3 FY2018 | Sep 30, 2018 | $10.99B | +5.2% |
| Q2 FY2018 | Jun 30, 2018 | $10.75B | +5.7% |
| Q1 FY2018 | Mar 31, 2018 | $10.70B | +5.8% |
| Q4 FY2017 | Dec 31, 2017 | $10.50B | +4.0% |
| Q3 FY2017 | Sep 30, 2017 | $10.44B | – |
| Q2 FY2017 | Jun 30, 2017 | $10.17B | – |
| Q1 FY2017 | Mar 31, 2017 | $10.11B | – |
| Q4 FY2016 | Dec 31, 2016 | $10.10B | – |
See a number that looks wrong?